Literature DB >> 8384624

Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction.

D Matteucci1, F Baldinotti, P Mazzetti, M Pistello, P Bandecchi, R Ghilarducci, A Poli, F Tozzini, M Bendinelli.   

Abstract

The rates of feline immunodeficiency virus (FIV) isolation from saliva, plasma, and peripheral blood mononuclear cells (PBMC) of infected cats were compared; isolation rates were 18, 14, and 81%, respectively, in naturally infected cats and 25, 57, and 100%, respectively, in experimentally infected animals. There was no obvious relationship between isolation rate and clinical stage or between isolation rate and the titer of neutralizing antibody in serum. Virus could be isolated from one salivary gland as early as 1 week postinfection and, on a more regular basis, starting at 3 weeks postinfection, when, however, most other tissues were also positive. Polymerase chain reaction analysis showed that FIV genomes are present in saliva and plasma more frequently than expected on the basis of isolation data. Saliva was also found to contain viral DNA, indicating that it may harbor virus-infected cells as well as free virus. The addition of plasma but not of saliva to PBMC cultures delayed FIV growth. Isolation from plasma may be hampered by FIV neutralizing antibody and by the cytotoxic activity of this fluid for the PBMC used as a cell substrate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384624      PMCID: PMC262808          DOI: 10.1128/jcm.31.3.494-501.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Saliva can contribute in quick inhibition of HIV infectivity.

Authors:  M Pourtois; C Binet; N Van Tieghem; P R Courtois; A Vandenabbeele; L Thirty
Journal:  AIDS       Date:  1991-05       Impact factor: 4.177

2.  HIV in saliva.

Authors:  J A Levy; D Greenspan
Journal:  Lancet       Date:  1988-11-26       Impact factor: 79.321

3.  Detection of proviral sequences in saliva of patients infected with human immunodeficiency virus type 1.

Authors:  Y Goto; C K Yeh; A L Notkins; B S Prabhakar
Journal:  AIDS Res Hum Retroviruses       Date:  1991-03       Impact factor: 2.205

4.  Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children.

Authors:  P C Fox; A Wolff; C K Yeh; J C Atkinson; B J Baum
Journal:  J Am Dent Assoc       Date:  1989-06       Impact factor: 3.634

5.  Efficient isolation of HIV from plasma during different stages of HIV infection.

Authors:  A Ehrnst; A Sönnerborg; S Bergdahl; O Strannegård
Journal:  J Med Virol       Date:  1988-09       Impact factor: 2.327

6.  The polymerase chain reaction for the detection of HIV-1 genomic RNA in plasma from infected individuals.

Authors:  M Ottmann; P Innocenti; M Thenadey; M Micoud; F Pelloquin; J M Seigneurin
Journal:  J Virol Methods       Date:  1991 Feb-Mar       Impact factor: 2.014

7.  Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission.

Authors:  J K Yamamoto; H Hansen; E W Ho; T Y Morishita; T Okuda; T R Sawa; R M Nakamura; N C Pedersen
Journal:  J Am Vet Med Assoc       Date:  1989-01-15       Impact factor: 1.936

8.  Plasma viremia in human immunodeficiency virus infection.

Authors:  R W Coombs; A C Collier; J P Allain; B Nikora; M Leuther; G F Gjerset; L Corey
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

9.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

Authors:  S J Clark; M S Saag; W D Decker; S Campbell-Hill; J L Roberson; P J Veldkamp; J C Kappes; B H Hahn; G M Shaw
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

10.  Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

Authors:  J K Yamamoto; E Sparger; E W Ho; P R Andersen; T P O'Connor; C P Mandell; L Lowenstine; R Munn; N C Pedersen
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

View more
  17 in total

Review 1.  Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.

Authors:  A D Kashuba; J R Dyer; L M Kramer; R H Raasch; J J Eron; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies.

Authors:  D Matteucci; M Pistello; P Mazzetti; S Giannecchini; D Del Mauro; L Zaccaro; P Bandecchi; F Tozzini; M Bendinelli
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

3.  Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.

Authors:  D Matteucci; A Poli; P Mazzetti; S Sozzi; F Bonci; P Isola; L Zaccaro; S Giannecchini; M Calandrella; M Pistello; S Specter; M Bendinelli
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.

Authors:  S Lombardi; C Garzelli; M Pistello; C Massi; D Matteucci; F Baldinotti; G Cammarota; L da Prato; P Bandecchi; F Tozzini
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Detection of feline immunodeficiency virus in semen from seropositive domestic cats (Felis catus).

Authors:  H L Jordan; J Howard; W A Tompkins; S Kennedy-Stoskopf
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Neutralizing antibodies in cats infected with feline immunodeficiency virus.

Authors:  F Tozzini; D Matteucci; P Bandecchi; F Baldinotti; K Siebelink; A Osterhaus; M Bendinelli
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

Review 7.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.

Authors:  F Baldinotti; D Matteucci; P Mazzetti; C Giannelli; P Bandecchi; F Tozzini; M Bendinelli
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection.

Authors:  R K Sellon; H L Jordan; S Kennedy-Stoskopf; M B Tompkins; W A Tompkins
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Using dynamic stochastic modelling to estimate population risk factors in infectious disease: the example of FIV in 15 cat populations.

Authors:  David Fouchet; Guillaume Leblanc; Frank Sauvage; Micheline Guiserix; Hervé Poulet; Dominique Pontier
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.